This expert-led course provides an overview of pharmacology broken down into five sections.  The first four sections cover cytotoxic therapies, overviewing DNA-damaging agents, microtubule toxins, and antimetabolites.  The fifth section focuses on drug interactions in oncology and their importance in patient care.  

Learning Objectives

  • Describe the mechanistic action of different DNA-damaging agents and apply knowledge of DNA-damaging agents to anticipate side effects and learn common toxicities
  • Describe the mechanistic action of different microtubule toxins and antimetabolites and apply knowledge of microtubule toxins and antimetabolites to anticipate side effects and learn common toxicities
  • Briefly describe pathways of drug-drug interactions in oncology

Continuing Education Credit

2.5 Credits/Points are available for participation in this course. Certificate and credit types available include:

  • AMA PRA Category 1 Credits
  • ABIM MOC Points
  • CNE Contact Hours
  • ONCC ILNA Points in Treatment Modalities
  • CPE Credits
  • Certificate of Participation may be used to confer credit; however, all final decisions regarding the awarding of credits will be made by the licensing organization to which the credits are submitted. 
  • Certificate of Completion may be used to document participation, but no credit will be conferred.
Important Notes
  • This course expires on March 23, 2019. Participants must complete all necessary course components by this date to receive credit.